Best Paper Award
Selective Inhibition of Proofreading Exonucleases The Central Role in Obesity Assoviated Carciniogenesis
The Best Paper Award recognizes the scholarly contribution of John Byrnes of the University of Miami for research examining the relationship between proofreading exonucleases and obesity-associated carcinogenesis. Published in MDPI during 2026, the study contributes to ongoing discussions in biochemistry, genetics, and molecular biology regarding genomic integrity, cancer development, and molecular mechanisms associated with metabolic disorders. The award acknowledges the scientific significance, methodological rigor, and interdisciplinary relevance of the publication within contemporary biomedical research.[1]
Abstract
This award-recognized research investigates the potential role of proofreading exonucleases in mechanisms associated with obesity-related carcinogenesis. The study explores how alterations in DNA replication fidelity, repair pathways, and genomic maintenance may contribute to cellular transformation under metabolic stress conditions. Through molecular and biochemical analyses, the research evaluates the consequences of selective exonuclease inhibition and its implications for tumor development. Findings provide insights into interactions between obesity-associated biological environments and genomic instability. The work advances understanding of cancer biology while identifying potential molecular targets for future therapeutic development and translational biomedical investigations.[2]
Keywords
AMP; AMPK; carcinogenesis; DNA polymerase; fidelity; energy regulation; metabolism; mutation; obesity; proofreading exonuclease.
Introduction
The increasing prevalence of obesity has intensified scientific interest in understanding its relationship with cancer risk and progression. Researchers have identified multiple biological pathways linking metabolic dysregulation to genomic instability. This study focuses on proofreading exonucleases, enzymes responsible for maintaining DNA replication accuracy, and evaluates their relevance within obesity-associated carcinogenic processes that may influence disease initiation and progression.[2]
Research Profile
John Byrnes is affiliated with the University of Miami and has established a research portfolio within biochemistry, genetics, and molecular biology. With 138 indexed scholarly documents, 8,573 citations, and an h-index of 39, his academic contributions demonstrate sustained engagement in molecular mechanisms underlying human disease, cancer development, and genomic maintenance processes across diverse biomedical research domains.[3]
Scientific Background
Proofreading exonucleases play a critical role in correcting replication errors and preserving genome integrity. Deficiencies in these enzymatic systems can result in elevated mutation rates and increased susceptibility to malignant transformation. Previous investigations have linked obesity-related inflammation, oxidative stress, and metabolic disturbances with DNA damage, creating a scientific basis for examining interactions between exonuclease activity and carcinogenic pathways.[4]
Methodology
The research applies molecular biology and biochemical methodologies to investigate the consequences of selective proofreading exonuclease inhibition. Experimental analyses assess cellular responses, genomic integrity markers, and mechanisms associated with DNA repair regulation. By integrating laboratory observations with established cancer biology frameworks, the study evaluates how altered proofreading functions may contribute to carcinogenic processes under obesity-associated physiological conditions.[2]
Key Findings
The study identifies significant relationships between proofreading exonuclease activity and mechanisms that influence genomic stability. Results indicate that disruptions in proofreading functions may enhance mutation accumulation and contribute to cellular environments favorable to carcinogenesis. The findings support the hypothesis that obesity-associated biological stressors can interact with genomic maintenance pathways, potentially increasing cancer susceptibility through complex molecular mechanisms.[2]
Scientific Contributions
This research contributes to the growing body of knowledge connecting metabolic disease and cancer biology. By highlighting proofreading exonucleases as important molecular components within obesity-associated carcinogenesis, the study offers a framework for future investigations into diagnostic biomarkers and therapeutic interventions. The work also strengthens interdisciplinary connections between molecular genetics, oncology, and translational biomedical science.[4]
Conclusion
The Best Paper Award recognizes a publication that advances understanding of molecular mechanisms underlying obesity-associated cancer development. Through examination of proofreading exonucleases and genomic stability pathways, the research provides valuable scientific insights with potential relevance to future therapeutic strategies. Its contribution to contemporary biomedical literature reflects both methodological rigor and significance within the broader field of molecular oncology.[5]
External Links
References
- MDPI. (2026). Selective Inhibition of Proofreading Exonucleases The Central Role in Obesity Assoviated Carciniogenesis.
https://www.mdpi.com/1467-3045/48/4/346
- DOI Reference. Cell Biochemistry and Function, Volume 48, Issue 4.
https://doi.org/10.3390/cimb48040346
- Google Scholar. (n.d.). John Byrnes Author Profile.
https://scholar.google.com/citations?user=1kizaHgAAAAJ&hl=en&oi=sra
- MDPI. (2026). Journal Information and Publication Metadata.
https://www.mdpi.com/
- International Research Excellence and Best Paper Awards. (2026). Best Paper Award Recognition Program.
https://bestpaperawards.com/